J&J To Pay $23M To Settle Investors' Drug Recall Suit

Law360, Los Angeles (July 16, 2013, 4:28 PM EDT) -- Johnson & Johnson will pay $23 million to settle a shareholder class action alleging that the company failed to disclose manufacturing violations leading to the biggest recall of over-the-counter children's medicine in U.S. history, according to a Monday filing in New Jersey federal court.

Lead plaintiff Ronald Monk alleged that revelations over J&J's quality control failures in July 2010 led to a drop in the company's stock price, from $59.57 to $57.12, and that shareholders suffered as a result. The class consists of the thousands of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

MONK v. JOHNSON & JOHNSON et al


Case Number

3:10-cv-04841

Court

New Jersey

Nature of Suit

Securities/Commodities

Judge

Freda L. Wolfson

Date Filed

September 21, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.